Concepedia

A. Maroof

AM

Statistics

Publications

4

Citations

172

H-Index

4

Active since

2012

Affiliations

UCB Pharma (United Kingdom)(Current)

UCB Pharma (Belgium)

A. Maroof is an author at UCB Pharma (United Kingdom) specializing in psoriasis immunopathology, immunology, and interleukin 17 inhibition.

Publications per year

2012–2021

4

Publications

4

Therapeutic Vaccination With Recombinant Adenovirus Reduces Splenic Parasite Burden in Experimental Visceral Leishmaniasis

A. Maroof, Najmeeyah Brown, Barbara A. Smith et al. · The Journal of Infectious Diseases · 2012 · 74 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Bimekizumab for the treatment of moderate‐to‐severe plaque psoriasis: efficacy, safety, pharmacokinetics, pharmacodynamics and transcriptomics from a phase IIa, randomized, double‐blind multicentre study*

Ruth Oliver, James G. Krueger, Sophie Glatt et al. · British Journal of Dermatology · 2021 · 47 citations · Full text

Medicine, Dermatology, Pharmacology +13

Intra- and inter-rater reliability of jumping mechanography muscle function assessments.

Matheson La, Shaun Duffy, A. Maroof et al. · PubMed · 2013 · 39 citations

Education, Kinesiology, Sports Medicine +17

THU0038 Bimekizumab dual inhibition of IL-17A and IL-17F provides evidence of IL-17F contribution to chronic inflammation in disease-relevant cells

A. Maroof, Remi Okoye, Timothy Smallie et al. · Annals of the Rheumatic Diseases · 2017 · 12 citations · Full text

Life Sciences, Immunology, Clinical Immunology +16

1–4 of 4